Davie, A.; Traoré, S.; Giovannitti, M.; Pompilio, G.; Lambton, M.; Cakar, E.; Chatterjee, A. Cost-Effectiveness Analysis of Abemaciclib With Endocrine Therapy (ET) Versus ET Alone for HR+, HER2−, Node-Positive, High-Risk Early Breast Cancer in Italy. Grhta 2023, 10, 62-69.